Subscribe to our monthly newsletter to receive exclusive news updates and medical AI insights.
Examine the current challenges for coronary CTA reimbursement, the potential effects it will have on patient care, and what medical imagers can do to help improve reimbursement moving forward.
Keya Medical showcased its deep learning-based diagnostic and treatment solutions at the World Artificial Intelligence Conference 2021 (WAIC 2021) held in Shanghai.
Artificial intelligence has made its way into nearly every aspect of cardiovascular imaging. Learn more about six must-read articles on cardiovascular imaging AI that provide insight into the many ways AI can improve care delivery.
Recent research demonstrates that deep learning could facilitate opportunistic screening and allow for earlier prevention and management of patients with cardiovascular disease. Learn more about the present opportunities.
The concept of a Smart Hospital is evolving in 2021. Read how new hospital construction can anticipate climate change, decentralization of care delivery, and advances in medical science.
Deep learning-based CT-FFR has demonstrated potential in improving the diagnosis of patients with coronary artery disease. Learn more about how deep learning-based CT-FFR can help improve patient outcomes in this introductory guide.
The expression “time is brain” has been used to demonstrate the importance of urgency in treating stroke patients. Learn more about how AI can help transform the diagnosis and treatment of stroke patients to improve outcomes.
Keya Medical has received regulatory approval in China for its DeepVessel 3D Visualization Processing Software. The AI-based software medical device is designed for visualization reading of multiphase CT images and 3D models.
A new study conducted by researchers at the First Affiliated Hospital of Jinan University demonstrates that deep learning-based CT-FFR (DL-CTFFR) can reduce the need for invasive coronary angiography (ICA) and improve outcomes in patients with stable coronary artery disease (CAD).
Evidence is building in support of a coronary CTA-first strategy for evaluating patients with stable coronary artery disease. Learn more about the current evidence, guidelines, and recommendations.
Keya Medical’s President of R&D, Dr. Kunlin Cao, has been recognized on the 2021 Forbes China Up-and-Coming Businesswomen list. The list highlights 20 accomplished women who have each played a significant role in shaping China’s business landscape.
Researchers at Fuwai Hospital conducted a retrospective study to evaluate the performance of Keya Medical’s deep learning-based CT-FFR product in detecting hemodynamic changes in stenosis.
Cardiovascular disease (CVD) remains the leading cause of death for women in the U.S. In honor of American Heart Month, we are highlighting the differences in women’s risk factors and primary prevention to help manage CVD in women.